J A Dewar

3.6k total citations · 1 hit paper
46 papers, 2.6k citations indexed

About

J A Dewar is a scholar working on Cancer Research, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, J A Dewar has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Cancer Research, 20 papers in Oncology and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in J A Dewar's work include Breast Cancer Treatment Studies (20 papers), Breast Implant and Reconstruction (6 papers) and Breast Lesions and Carcinomas (6 papers). J A Dewar is often cited by papers focused on Breast Cancer Treatment Studies (20 papers), Breast Implant and Reconstruction (6 papers) and Breast Lesions and Carcinomas (6 papers). J A Dewar collaborates with scholars based in United Kingdom, United States and Australia. J A Dewar's co-authors include David Cameron, Michael Marmot, Douglas G. Altman, Simon G. Thompson, Colin McCowan, Peter T. Donnan, P E Preece, A.M. Thompson, Boikanyo Makubate and Robert A. Wood and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

J A Dewar

45 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The benefits and harms of breast cancer screening: an independent review

2013 731 citations Michael Marmot, Douglas G. Altman et al. British Journal of Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J A Dewar United Kingdom	19	1.3k	1.0k	482	357	326	46	2.6k
Katherine E. Reeder‐Hayes United States	30	1.5k 1.2×	774 0.8×	338 0.7×	172 0.5×	320 1.0×	160	2.9k
Michael J. Hassett United States	28	1.4k 1.0×	854 0.8×	310 0.6×	278 0.8×	507 1.6×	157	3.1k
Karen Gelmon Canada	18	2.1k 1.6×	1.9k 1.9×	1.0k 2.1×	813 2.3×	705 2.2×	29	4.2k
Manuela Rabaglio Switzerland	22	1.2k 0.9×	819 0.8×	779 1.6×	168 0.5×	589 1.8×	83	2.0k
Michael Braun Germany	29	1.4k 1.1×	770 0.8×	108 0.2×	436 1.2×	626 1.9×	156	2.9k
G Hoctin-Boes Netherlands	8	1.4k 1.0×	958 1.0×	1.5k 3.1×	133 0.4×	392 1.2×	12	2.4k
J S Tobias United Kingdom	11	1.3k 1.0×	715 0.7×	1.1k 2.3×	118 0.3×	402 1.2×	16	2.3k
Christos Markopoulos Greece	33	2.5k 1.9×	1.7k 1.7×	1.0k 2.1×	569 1.6×	615 1.9×	198	4.7k
J. Houghton United Kingdom	19	2.2k 1.7×	2.2k 2.2×	1.8k 3.7×	535 1.5×	644 2.0×	51	4.1k
Marc Debled France	30	1.9k 1.4×	1.5k 1.5×	635 1.3×	662 1.9×	1.1k 3.3×	121	3.8k

Countries citing papers authored by J A Dewar

Since Specialization

Citations

This map shows the geographic impact of J A Dewar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J A Dewar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J A Dewar more than expected).

Fields of papers citing papers by J A Dewar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J A Dewar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J A Dewar. The network helps show where J A Dewar may publish in the future.

Co-authorship network of co-authors of J A Dewar

This figure shows the co-authorship network connecting the top 25 collaborators of J A Dewar. A scholar is included among the top collaborators of J A Dewar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J A Dewar. J A Dewar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fumoleau, P., J A Dewar, Joan Albanell, et al.. (2016). Trastuzumab emtansine (T-DM1) plus docetaxel with or without pertuzumab in patients with HER2-positive locally advanced or metastatic breast cancer: results from a phase Ib/IIa study. Annals of Oncology. 27(7). 1249–1256. 45 indexed citations

Rea, Daniel, Richard Gray, S. Bowden, et al.. (2013). Overall and subgroup findings of the aTTom trial: A randomised comparison of continuing adjuvant tamoxifen to 10 years compared to stopping after 5 years in 6953 women with ER positive or ER untested early breast cancer. European Journal of Cancer. 49. 17 indexed citations

Purdie, Colin A., Philip Quinlan, Lee B. Jordan, et al.. (2013). Progesterone receptor expression is an independent prognostic variable in early breast cancer: a population-based study. British Journal of Cancer. 110(3). 565–572. 136 indexed citations

Martín, Miguel, et al.. (2013). Abstract P4-12-07: Neoadjuvant trastuzumab emtansine and docetaxel, with or without pertuzumab, in patients with HER2-positive early-stage breast cancer: Results from a phase 1b/2a study. Cancer Research. 73(24_Supplement). P4–12. 2 indexed citations

Marmot, Michael, et al.. (2013). The benefits and harms of breast cancer screening: an independent review. British Journal of Cancer. 108(11). 2205–2240. 731 indexed citations breakdown →

Bryant, Peter E., et al.. (2012). Topoisomerase II levels and G2 radiosensitivity in T-lymphocytes of women presenting with breast cancer. Mutagenesis. 27(6). 737–741. 3 indexed citations

Fong, Andrew, Jesmin Shafiq, Christobel Saunders, et al.. (2012). A comparison of surgical and radiotherapy breast cancer therapy utilization in Canada (British Columbia), Scotland (Dundee), and Australia (Western Australia) with models of “optimal” therapy. The Breast. 21(4). 570–577. 13 indexed citations

Purdie, Colin A., Lee D. Baker, A Ashfield, et al.. (2010). Increased mortality in HER2 positive, oestrogen receptor positive invasive breast cancer: a population-based study. British Journal of Cancer. 103(4). 475–481. 34 indexed citations

McCowan, Colin, Peter T. Donnan, J A Dewar, et al.. (2008). Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. British Journal of Cancer. 99(11). 1763–1768. 282 indexed citations

10.

Anderson, Annie S., J A Dewar, David Marshall, et al.. (2007). The development of a healthy eating indicator shopping basket tool (HEISB) for use in food access studies—identification of key food items. Public Health Nutrition. 10(12). 1440–1447. 83 indexed citations

11.

Thomson, C S, David Brewster, J A Dewar, & Chris Twelves. (2004). Improvements in survival for women with breast cancer in Scotland between 1987 and 1993: impact of earlier diagnosis and changes in treatment. European Journal of Cancer. 40(5). 743–753. 34 indexed citations

12.

Ferguson, Michelle & J A Dewar. (2002). Tamoxifen beyond 5 years—patients' decisions regarding entry to the aTTom trial. European Journal of Cancer. 38(14). 1857–1859. 6 indexed citations

13.

Twelves, Chris, C S Thomson, J A Dewar, & David Brewster. (2001). Variation in survival of women with breast cancer: Health Board remains a factor at 10 years. British Journal of Cancer. 85(5). 637–640. 14 indexed citations

14.

Dewar, J A, et al.. (1999). The Impact of the New Part VII Family Law Act 1975. Griffith Research Online (Griffith University, Queensland, Australia). 13. 96–116. 14 indexed citations

15.

Brewster, David, J A Dewar, Oleg Eremin, et al.. (1999). In pursuit of excellence for patients with cancer: the Scottish Cancer Therapy Network model. British Journal of Cancer. 79(11-12). 1641–1645. 3 indexed citations

16.

Everington, Dawn, et al.. (1996). Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. British Journal of Cancer. 74(2). 297–299. 118 indexed citations

17.

Dewar, J A, J M Horobin, P E Preece, et al.. (1992). Long term effects of tamoxifen on blood lipid values in breast cancer.. BMJ. 305(6847). 225–226. 80 indexed citations

18.

Arriagada, R., Monique G. Lê, H Mouriesse, et al.. (1988). Long-term effect of internal mammary chain treatment. Results of a multivariate analysis of 1195 patients with operable breast cancer and positive axillary nodes. Radiotherapy and Oncology. 11(3). 213–222. 89 indexed citations

19.

Dewar, J A, Simone Benhamou, E Benhamou, et al.. (1988). Cosmetic results following lumpectomy axillary dissection and radiotherapy for small breast cancers. Radiotherapy and Oncology. 12(4). 273–280. 103 indexed citations

20.

Dewar, J A. (1975). Hypotensive Treatment for Acute Myocardial Infarction. BMJ. 1(5960). 734.4–734. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact